Recruiting

TIzanidine for the Preventive Treatment of Episodic MigrainE （TIME）

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(6 sites)

China

The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang

The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang

Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang

The First Hospital of Jiaxing, Jiaxing, Zhejiang

Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang